15 Years of Trust in Saving Nephrons

Evidence based Nephroprotective Nutraceutical to slow the progression of CKD

15-Years Logo
15-Years Logo
15-Years Logo

Nefrosave & Nefrosave Forte are the patented products of Fourrts
Nefrosave Patent No. IN300350
Nefrosave Forte Patent No. IN339847

Nefrosave is the No.1 Anti-oxidant brand prescribed by Nephrologists in India*

Fourrts Awareness Initiative

Obrien Feature

Statewise Incidence of Microalbuminuria
First Time in India

  • Conducted over 6000 Micral Camps
  • Screened over 72000 Patients

Microalbuminuria

Prevalence in India

46%

Int. J. Adv. Med. 2019
Prevalence of nephropathy detected through microalbuminuria in type 2 DM was 44.7%

J. Assoc. Physicians India. 2018
Prevalence of microalbuminuria in essential hypertension was 47%

"As physicians, we take a solemn oath to serve our patients and community, to do no harm and always put our patients first. At Fourrts, we use the same guiding principles to manufacture and market quality pharmaceutical formulations to serve patients in India and across the globe. We understand the emotional and economic ramifications of chronic disease and seek to be your partner in providing the best care for our patients"

Dr. Gayatri Veeramani Jayaraman M.D., MHA (USA)

American Board Certified Physician & Nephrologist (ABIM)
Director of Marketing & International Business - Fourrts

Physicians

Physicians

Patients

Patients

Artificial Intelligence: Clinical Applications in Nephrology

Keto-Alfa analogues supplementation - A New Era By Dr.Garneata